Intuitive Surgical Appoints David Rosa as CEO

Intuitive Surgical ( (ISRG) ) has provided an update.

On May 14, 2025, Intuitive Surgical‘s Board of Directors appointed David J. Rosa as the new Chief Executive Officer, effective July 1, 2025. Rosa, who has been with the company for 29 years, will replace Gary S. Guthart, who will transition to Executive Chair of the Board. This leadership change is part of the company’s strategic succession planning to drive future growth. The announcement highlights Rosa’s extensive experience and contributions to Intuitive’s strategy and product development, positioning him as the right leader to continue advancing the company’s mission and expanding its global footprint.

The most recent analyst rating on (ISRG) stock is a Buy with a $525.00 price target. To see the full list of analyst forecasts on Intuitive Surgical stock, see the ISRG Stock Forecast page.

Spark’s Take on ISRG Stock

According to Spark, TipRanks’ AI Analyst, ISRG is a Outperform.

Intuitive Surgical’s overall stock score reflects its robust financial performance, characterized by strong profitability, growth, and liquidity. Positive earnings call guidance further enhances its outlook, despite high valuation concerns and moderate technical indicators. Challenges such as tariff impacts and international market stresses are notable but are balanced by the company’s strategic strengths and innovation initiatives.

To see Spark’s full report on ISRG stock, click here.

More about Intuitive Surgical

Intuitive Surgical, Inc., headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic-assisted surgery. The company offers technologies including the da Vinci surgical systems and the Ion endoluminal system, aiming to enhance care delivery and patient outcomes.

Average Trading Volume: 2,299,815

Technical Sentiment Signal: Strong Buy

Current Market Cap: $202.1B

See more insights into ISRG stock on TipRanks’ Stock Analysis page.